0001209191-17-046462.txt : 20170727 0001209191-17-046462.hdr.sgml : 20170727 20170727172315 ACCESSION NUMBER: 0001209191-17-046462 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170725 FILED AS OF DATE: 20170727 DATE AS OF CHANGE: 20170727 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tammenoms Bakker Juliet CENTRAL INDEX KEY: 0001431159 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38150 FILM NUMBER: 17987132 MAIL ADDRESS: STREET 1: LONGITUDE CAPITAL MANAGEMENT CO., LLC STREET 2: 800 EL CAMINO REAL, SUITE 220 CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ENRIGHT PATRICK G CENTRAL INDEX KEY: 0001253886 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38150 FILM NUMBER: 17987133 MAIL ADDRESS: STREET 1: CO LONGITUDE CAPITAL PARTNERS LLC STREET 2: 800 EL CAMINO REAL, SUITE 220 CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Longitude Capital Partners II, LLC CENTRAL INDEX KEY: 0001647491 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38150 FILM NUMBER: 17987130 BUSINESS ADDRESS: STREET 1: 800 EL CAMINO REAL STREET 2: SUITE 220 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-854-5700 MAIL ADDRESS: STREET 1: 800 EL CAMINO REAL STREET 2: SUITE 220 CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Longitude Venture Partners II, L.P. CENTRAL INDEX KEY: 0001527510 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38150 FILM NUMBER: 17987131 BUSINESS ADDRESS: STREET 1: 800 EL CAMINO REAL, SUITE 220 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-854-5700 MAIL ADDRESS: STREET 1: 800 EL CAMINO REAL, SUITE 220 CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kala Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001479419 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270604595 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 BEAVER STREET STREET 2: SUITE 201 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 781-996-5252 MAIL ADDRESS: STREET 1: 100 BEAVER STREET STREET 2: SUITE 201 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-25 1 0001479419 Kala Pharmaceuticals, Inc. KALA 0001647491 Longitude Capital Partners II, LLC 800 EL CAMINO REAL SUITE 220 MENLO PARK CA 94025 0 0 1 0 0001253886 ENRIGHT PATRICK G 800 EL CAMINO REAL SUITE 220 MENLO PARK CA 94025 0 0 1 0 0001431159 Tammenoms Bakker Juliet 800 EL CAMINO REAL SUITE 220 MENLO PARK CA 94025 0 0 1 0 0001527510 Longitude Venture Partners II, L.P. 800 EL CAMINO REAL SUITE 220 MENLO PARK CA 94025 0 0 1 0 Common Stock 2017-07-25 4 C 0 2055946 A 2055946 I By Longitude Venture Partners II, L.P. Common Stock 2017-07-25 4 P 0 215000 15.00 A 2270946 I By Longitude Venture Partners II, L.P. Series C Preferred Stock 2017-07-25 4 C 0 10707985 0.00 D Common Stock 2055946 0 I By Longitude Venture Partners II, L.P. The Series C Preferred Stock converted into Common Stock on a 5.2083-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. This Form 4 is filed jointly by Longitude Capital Partners II, LLC ("Longitude Capital II"), Longitude Venture Partners II, L.P. ("Longitude Venture II"), Patrick G. Enright ("Mr. Enright") and Juliet Tammenoms Bakker ("Ms. Bakker"), all of whom shared beneficial ownership of more than 10% of the capital stock of the Issuer as of the date of the transactions reported in this Form 4. Longitude Capital II is the general partner of Longitude Venture II and may be deemed to share voting and investment power over the shares held by Longitude Venture II. Mr. Enright and Ms. Bakker are the managing members of Longitude Capital II and may be deemed to share voting and investment power over the shares held by Longitude Venture II. Each of Longitude Capital II, Mr. Enright and Ms. Bakker disclaims beneficial ownership of such shares except to the extent of its, his or her pecuniary interest therein. Longitude Venture II acquired 215,000 shares of Common Stock in the Issuer's initial public offering. /s/ Patrick G. Enright 2017-07-27 /s/ Patrick G. Enright 2017-07-27 /s/ Juliet Tammenoms Bakker 2017-07-27 /s/ Patrick G. Enright 2017-07-27